A Case Report of Biotin Treatment for Valproate-Induced Hair Loss
August 2017
in “
The Journal of Clinical Psychiatry
”
Studysummary In this letter, excessive hair loss due to telogen effluvium was observed as a distressing side effect in the early months of valproate treatment, potentially linked to disruption in biotin metabolism, although the exact mechanism remains unclear.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on psychiatrist.com →